Kingworld Medicines Group Limited (1110.HK)
HKD 0.45
(1.12%)
HKD 0.45
(1.12%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.07 Billion | 957.7 Million | 847.38 Million | 745.38 Million | 977.92 Million | 1.07 Billion |
| Cost of Revenue | 797.99 Million | 680.07 Million | 583.78 Million | 465.22 Million | 710.52 Million | 767.34 Million |
| Gross Profit | 280.66 Million | 277.62 Million | 263.59 Million | 280.15 Million | 267.4 Million | 311.49 Million |
| Operating Expenses | 183.85 Million | 214.47 Million | 204.66 Million | 246.32 Million | 232.1 Million | 265.96 Million |
| Selling, General and Administrative Expenses | 222.29 Million | 205.02 Million | 196.15 Million | 245.5 Million | 219.72 Million | 251.42 Million |
| Research and Development Expenses | 18.84 Million | 15.51 Million | 13.4 Million | 13.25 Million | 15.07 Million | 13.87 Million |
| Other Expenses | -57.27 Million | 9.45 Million | 8.51 Million | 815 Thousand | 12.38 Million | 17.76 Million |
| Cost and Expenses | 981.85 Million | 894.55 Million | 788.45 Million | 711.55 Million | 942.63 Million | 1.03 Billion |
| Operating Income | 96.8 Million | 72.23 Million | 72.22 Million | 73.64 Million | 76.74 Million | 68.84 Million |
| Interest Expense | 11.51 Million | 12.29 Million | 11.78 Million | 15.16 Million | 15.48 Million | 17 Million |
| Income Tax Expense | 32.29 Million | 24.04 Million | 18.22 Million | 20 Million | 19.53 Million | 18.62 Million |
| Earnings before Tax | 93.88 Million | 67.58 Million | 69.43 Million | 70.89 Million | 69.8 Million | 70.38 Million |
| Net Income | 38.09 Million | 43.54 Million | 51.21 Million | 50.88 Million | 43.42 Million | 41 Million |
| Earnings Per Share Basic | 0.06 | 0.07 | 0.08 | 0.08 | 0.07 | 0.07 |
| Earnings Per Share Diluted | 0.06 | 0.07 | 0.08 | 0.08 | 0.07 | 0.07 |
| Weighted Average Shares Outstanding | 591.63 Million | 606.71 Million | 606.5 Million | 614.4 Million | 620.62 Million | 622.5 Million |
| Weighted Average Shares Outstanding (Diluted) | 591.62 Million | 622.5 Million | 622.5 Million | 614.4 Million | 620.62 Million | 622.5 Million |
| Gross Margin | 0.26 | 0.29 | 0.31 | 0.38 | 0.27 | 0.29 |
| EBIT Margin | 0.10 | 0.12 | 0.14 | 0.17 | 0.12 | 0.11 |
| Profit Margin | 0.04 | 0.05 | 0.06 | 0.07 | 0.04 | 0.04 |
| EBITDA | 112.98 Million | 118.06 Million | 116 Million | 120.58 Million | 121.61 Million | 116.18 Million |
| Earnings Before Tax Margin | 0.09 | 0.08 | 0.09 | 0.10 | 0.08 | 0.06 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 263.04 Million | 263.04 Million | 1.07 Billion | 262.82 Million | 262.82 Million | 276.5 Million |
| Cost of Revenue | 194.41 Million | 194.41 Million | 797.99 Million | 199.83 Million | 199.83 Million | 199.16 Million |
| Gross Profit | 68.62 Million | 68.62 Million | 280.66 Million | 62.98 Million | 62.98 Million | 77.34 Million |
| Operating Expenses | 39.66 Million | 39.66 Million | 217.97 Million | 44.68 Million | 49.16 Million | 44.22 Million |
| Selling, General and Administrative Expenses | 45.63 Million | 45.63 Million | - | 60.36 Million | 60.36 Million | 51 Million |
| Research and Development Expenses | 3.37 Million | 3.37 Million | - | 6.2 Million | 6.2 Million | 3.21 Million |
| Other Expenses | -9.34 Million | -9.34 Million | 16.42 Million | -21.87 Million | - | - |
| Cost and Expenses | 234.07 Million | 234.07 Million | 1.01 Billion | 244.52 Million | 248.99 Million | 243.39 Million |
| Operating Income | 28.96 Million | 28.96 Million | 96.8 Million | 18.3 Million | 10.38 Million | 28.95 Million |
| Interest Expense | - | - | 11.51 Million | - | - | 10.69 Million |
| Income Tax Expense | 4.92 Million | 4.92 Million | 32.29 Million | 11.16 Million | 11.16 Million | 4.97 Million |
| Earnings before Tax | 27.73 Million | 27.73 Million | 93.88 Million | 18.11 Million | 18.11 Million | 28.82 Million |
| Net Income | 15.35 Million | 15.35 Million | 38.09 Million | 184.5 Thousand | 184.5 Thousand | 18.86 Million |
| Earnings Per Share Basic | 0.03 | 0.03 | - | 0.00 | 0.00 | 0.03 |
| Earnings Per Share Diluted | 0.03 | 0.03 | - | 0.00 | 0.00 | 0.03 |
| Weighted Average Shares Outstanding | 590.82 Million | 590.82 Million | 591.63 Million | 595.16 Million | 595.16 Million | 591.36 Million |
| Weighted Average Shares Outstanding (Diluted) | 590.81 Million | 590.81 Million | 591.62 Million | 591.89 Million | 591.89 Million | 591.35 Million |
| Gross Margin | 0.26 | 0.26 | 0.26 | 0.24 | 0.24 | 0.28 |
| EBIT Margin | 0.12 | 0.12 | - | 0.05 | 0.05 | 0.12 |
| Profit Margin | 0.06 | 0.06 | 0.04 | 0.00 | 0.00 | 0.07 |
| EBITDA | 30.85 Million | 30.85 Million | - | 12.09 Million | 12.09 Million | 32.16 Million |
| Earnings Before Tax Margin | 0.11 | 0.11 | 0.09 | 0.07 | 0.04 | 0.10 |
0HH6
4839
OPTI
FC9
215600
SAMCO